Merck KGaA (MKGAF)
153.21
+2.30
(+1.52%)
USD |
OTCM |
Feb 13, 15:53
Merck EPS Diluted (Quarterly) : 2.424 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| MediGene AG | -- |
| InflaRx NV | -0.2115 |
| BioNTech SE | -0.1395 |
| Immatics NV | -0.4859 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 1.049B |
| Revenue (Quarterly) | 6.215B |
| Total Expenses (Quarterly) | 5.161B |
| Enterprise Value | 77.26B |
| Gross Profit Margin (Quarterly) | 60.42% |
| Profit Margin (Quarterly) | 16.89% |
| Earnings Yield | 4.92% |
| Operating Earnings Yield | 7.46% |
| Normalized Earnings Yield | 5.285 |